CONMED (CNMD) PT Raised to $83 at Needham & Company

August 2, 2018 6:43 AM

Needham & Company raised its price target on CONMED (NASDAQ: CNMD) to $83.00 (from $73.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found